<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01958931</url>
  </required_header>
  <id_info>
    <org_study_id>FML - 204</org_study_id>
    <nct_id>NCT01958931</nct_id>
  </id_info>
  <brief_title>Evaluate the Utility of the ProLung Test as Adjunctive to CT Scan in the Diagnosis of Lung Cancer</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fresh Medical Laboratories</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fresh Medical Laboratories</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Study to evaluate the utility of the ProLung Test as an adjunct to CT scan in the diagnosis
      of lung cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This Study will assess the stability of the ProLung Test classification algorithm when used
      as an adjunct to CT scan. This Study will assess whether there are any potential safety
      concerns of the ProLung Test when used to evaluate patients with a positive CT scan for lung
      cancer.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ProLung Test utility in lung cancer</measure>
    <time_frame>date of conclusive diagnosis</time_frame>
    <description>This Study will assess the stability of the ProLung Test classification algorithm when used as an adjunct to CT scan to determine whether it is appropriate to be used in a pivotal study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety and Tolerability of the ProLung Test</measure>
    <time_frame>within 30 minutes of the ProLung Test</time_frame>
    <description>This Study will assess whether there are any potential safety concerns of the ProLung Test when used to evaluate patients with a positive CT scan for lung cancer.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">55</enrollment>
  <condition>Solitary Pulmonary Nodule</condition>
  <condition>Multiple Pulmonary Nodules</condition>
  <arm_group>
    <arm_group_label>Patients Suspicious for Lung Cancer</arm_group_label>
    <description>Subjects are symptomatic of lung cancer and have one or more lung nodules or lung masses suspicious for lung cancer.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with lung cancer symptoms and pulmonary lesions suspicious for lung cancer
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is male or female, age 18 or above.

          -  If female, subject

               -  is of non-childbearing potential meaning permanently sterile, or

               -  is one year post-menopausal; or

               -  is not pregnant as confirmed by negative urine pregnancy test and using adequate
                  birth control at time of screening.

          -  Subject presents with one or more of the following clinical symptoms or suspicious
             radiological finding(s):

               -  Persistent cough

               -  Hoarseness

               -  Shortness of breath

               -  Sputum streaked with blood

               -  Fatigue

               -  Unexplained recent weight loss

               -  Recurrent pneumonia or bronchitis

               -  Chest pain

               -  Abnormal chest radiograph

          -  Subject has undergone a CT scan of the lungs within 44 days of measurement that
             indicates one or more non-calcified nodules (NCN) or lung masses suspicious for lung
             cancer.

          -  Subject is capable of understanding and agreeing to fulfill the requirements of this
             protocol.

          -  Subject has signed the IRB/IEC approved informed consent form.

        Exclusion Criteria:

        â€¢ Subjects who meet one or more of the following criteria may not be enrolled in this
        Study:

          -  Subject has a pacemaker or other implanted electronic device.

          -  Subject with diagnosed malignancy within the past 5 (five) years except for
             non-melanoma skin cancer.

          -  Subject with significant systemic diseases including uncontrolled diabetes, severe
             heart failure, uncontrolled hypertension, myocardial infarction and/or auto-immune
             conditions within the prior 3 (three) months.

          -  Subject taking systemic corticosteroid medication (except for inhaled) within 14 days
             prior to measurement session.

          -  Subject has had an invasive medical procedure that involves the thoracic cavity within
             30 days prior to the measurement session.

          -  Subject who currently abuses alcohol or drugs.

          -  Subject presents with an anomalous physical or anatomical condition that precludes
             measurement.

          -  Subject will have undergone unusually strenuous exercise within 24 hours prior to
             measurement session.

          -  Subject who has, in the Principal Investigator's opinion, any medical condition or
             other circumstance that would prevent completion of this Study or interfere with
             analysis of the Study results.

          -  Subjects who have undergone radiation and chemotherapy treatment within the past 30
             days.

          -  Subject receiving therapy for documented or suspected chest infection.

          -  Pregnant or lactating females.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Johns Hopkins School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2013</study_first_submitted>
  <study_first_submitted_qc>October 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 9, 2013</study_first_posted>
  <last_update_submitted>October 8, 2013</last_update_submitted>
  <last_update_submitted_qc>October 8, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 9, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Pulmonary Nodules</mesh_term>
    <mesh_term>Solitary Pulmonary Nodule</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

